HCA Holdings, Inc. (NYSE:HCA)‘s stock had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald in a report released on Wednesday. They currently have a $95.00 target price on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 22.93% from the company’s current price.

Several other equities research analysts have also recently commented on HCA. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a research note on Friday, July 14th. BidaskClub lowered HCA Holdings from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Argus initiated coverage on HCA Holdings in a report on Wednesday, June 28th. They set a “buy” rating and a $100.00 target price on the stock. Leerink Swann raised HCA Holdings from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $92.00 to $100.00 in a report on Tuesday, June 6th. Finally, Morgan Stanley assumed coverage on HCA Holdings in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $90.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company. HCA Holdings has a consensus rating of “Buy” and a consensus target price of $92.81.

Shares of HCA Holdings (NYSE:HCA) traded down 0.938% during mid-day trading on Wednesday, hitting $76.555. 2,014,099 shares of the company traded hands. The firm has a 50-day moving average price of $79.72 and a 200 day moving average price of $83.89. The firm has a market cap of $27.66 billion, a price-to-earnings ratio of 10.262 and a beta of 0.67. HCA Holdings has a 52-week low of $67.00 and a 52-week high of $91.03.

HCA Holdings (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business had revenue of $10.73 billion for the quarter, compared to the consensus estimate of $10.76 billion. During the same quarter last year, the firm earned $1.66 EPS. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. Equities research analysts anticipate that HCA Holdings will post $7.18 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “HCA Holdings’ (HCA) Buy Rating Reiterated at Cantor Fitzgerald” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/09/07/hca-holdings-hca-buy-rating-reiterated-at-cantor-fitzgerald.html.

In related news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction on Monday, July 17th. The stock was sold at an average price of $86.44, for a total transaction of $185,846.00. Following the sale, the insider now directly owns 12,363 shares in the company, valued at $1,068,657.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jonathan B. Perlin sold 71,063 shares of HCA Holdings stock in a transaction on Thursday, June 22nd. The stock was sold at an average price of $86.00, for a total value of $6,111,418.00. The disclosure for this sale can be found here. Insiders have sold 77,513 shares of company stock worth $6,651,455 over the last quarter. 2.90% of the stock is currently owned by corporate insiders.

Institutional investors have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. lifted its holdings in HCA Holdings by 14.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after acquiring an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. lifted its holdings in HCA Holdings by 35.1% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after acquiring an additional 320 shares during the period. Atlantic Trust LLC bought a new stake in HCA Holdings during the second quarter worth $118,000. Lee Financial Co bought a new stake in HCA Holdings during the second quarter worth $125,000. Finally, Acrospire Investment Management LLC lifted its holdings in HCA Holdings by 14.3% during the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after acquiring an additional 200 shares during the period. Institutional investors and hedge funds own 73.77% of the company’s stock.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.